Comparing Efficacy of Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation With Conventional Chemo-(Immuno) Therapy in Patients With Relapsed or Refractory CLL: A Markov Decision Analysis

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2012.71
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search